Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1981 AL 1995

Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods: study protocol

Rodríguez-Molinero A, Hernández-Vara J, Miñarro A, Pérez-López C, Bayes-Rusiñol À, Martínez-Castrillo JC, Pérez-Martínez DA; Monitoring Parkinson’s patients Mobility for therapeutic purposes research group.

BMJ Open. 2021 Jul 19;11(7):e045272. doi: 10.1136/bmjopen-2020-045272.

The effect of body weight-supported overground gait training for patients with Parkinson's disease: A retrospective case-control observational study

Koyanagi Y, Fukushi I, Nakamura M, Suzuki K, Oda N, Aita T, Seki H.

PLoS One. 2021 Jul 20;16(7):e0254415. doi: 10.1371/journal.pone.0254415. eCollection 2021.

Changes in Epidemiological Trends and Rehabilitation Usage in Neurological Diseases in Korea: Parkinson's Disease

Yun SJ, Seo HG.

Brain Neurorehabil. 2021 Jul 21;14(2):e12. doi: 10.12786/bn.2021.14.e12. eCollection 2021 Jul.

Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?

Grieb P, Rejdak K.

Folia Neuropathol. 2021;59(2):113-120. doi: 10.5114/fn.2021.107572.

Cerebral Dopamine Neurotrophic Factor (CDNF): Structure, Functions, and Therapeutic Potential

Eremin DV, Ilchibaeva TV, Tsybko AS.

Biochemistry (Mosc). 2021 Jul;86(7):852-866. doi: 10.1134/S0006297921070063.

Reassessing neurodegenerative disease: immune protection pathways and antagonistic pleiotropy

Provenzano F, Deleidi M.

Trends Neurosci. 2021 Oct;44(10):771-780. doi: 10.1016/j.tins.2021.06.006. Epub 2021 Jul 17.

The Effects of Yoga on Patients with Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials

Ban M, Yue X, Dou P, Zhang P.

Behav Neurol. 2021 Jul 5;2021:5582488. doi: 10.1155/2021/5582488. eCollection 2021.

Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease

Shin EJ, Jeong JH, Hwang Y, Sharma N, Dang DK, Nguyen BT, Nah SY, Jang CG, Bing G, Nabeshima T, Kim HC.

Arch Pharm Res. 2021 Jul;44(7):668-688. doi: 10.1007/s12272-021-01341-7. Epub 2021 Jul 20.

Converging dopaminergic neurotoxicity mechanisms of antipsychotics, methamphetamine and levodopa

Zareifopoulos N, Skaltsa M, Dimitriou A, Karveli M, Efthimiou P, Lagadinou M, Tsigkou A, Velissaris D.

Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4514-4519. doi: 10.26355/eurrev_202107_26243.

Action Observation and Motor Imagery Improve Dual Task in Parkinson's Disease: A Clinical/fMRI Study

Sarasso E, Agosta F, Piramide N, Gardoni A, Canu E, Leocadi M, Castelnovo V, Basaia S, Tettamanti A, Volontè MA, Filippi M.

Mov Disord. 2021 Nov;36(11):2569-2582. doi: 10.1002/mds.28717. Epub 2021 Jul 19.

Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial)

Iorio-Morin C, Yamamoto K, Sarica C, Zemmar A, Levesque M, Brisebois S, Germann J, Loh A, Boutet A, Elias GJB, Azevedo P, Adam E, Patel U, Lenis M, Kalia SK, Hodaie M, Fasano A, Lozano AM.

Mov Disord. 2021 Nov;36(11):2653-2662. doi: 10.1002/mds.28716. Epub 2021 Jul 20.

International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease

Laansma MA, Bright JK, Al-Bachari S, Anderson TJ, Ard T, Assogna F, Baquero KA, Berendse HW, Blair J, Cendes F, Dalrymple-Alford JC, de Bie RMA, Debove I, Dirkx MF, Druzgal J, Emsley HCA, Garraux G, Guimarães RP, Gutman BA, Helmich RC, Klein JC, Mackay CE, McMillan CT, Melzer TR, Parkes LM, Piras F, Pitcher TL, Poston KL, Rango M, Ribeiro LF, Rocha CS, Rummel C, Santos LSR, Schmidt R, Schwingenschuh P, Spalletta G, Squarcina L, van den Heuvel OA, Vriend C, Wang JJ, Weintraub D, Wiest R, Yasuda CL, Jahanshad N, Thompson PM, van der Werf YD; ENIGMA-Parkinson's Study.

Mov Disord. 2021 Nov;36(11):2583-2594. doi: 10.1002/mds.28706. Epub 2021 Jul 20.

Trial of Pimavanserin in Dementia-Related Psychosis

Tariot PN, Cummings JL, Soto-Martin ME, Ballard C, Erten-Lyons D, Sultzer DL, Devanand DP, Weintraub D, McEvoy B, Youakim JM, Stankovic S, Foff EP.

N Engl J Med. 2021 Jul 22;385(4):309-319. doi: 10.1056/NEJMoa2034634.

The Metallome as a Link Between the "Omes" in Autism Spectrum Disorders

Stanton JE, Malijauskaite S, McGourty K, Grabrucker AM.

Front Mol Neurosci. 2021 Jul 5;14:695873. doi: 10.3389/fnmol.2021.695873. eCollection 2021.

Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system

How Shing Koy E, Labauge P, Baillet A, Prati C, Marotte H, Pers YM.

Ther Adv Musculoskelet Dis. 2021 Jul 9;13:1759720X211025894. doi: 10.1177/1759720X211025894. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias